Ferran Fece de la Cruz

Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

Aparna R. Parikh, Ignaty Leshchiner, Liudmila Elagina et al. · Nature Medicine · 2019 · 522 citations

Medicine, Oncology, Pathology +16

TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

Lipika Goyal, Lei Shi, Leah Y. Liu et al. · Cancer Discovery · 2019 · 371 citations · Full text

Medicine, Oncology, Pharmacology +17

A reversible gene trap collection empowers haploid genetics in human cells

Tilmann Bürckstümmer, Carina Banning, Philipp Hainzl et al. · Nature Methods · 2013 · 110 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

Co-occurring Alterations in the RAS–MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer

Julia Rotow, Philippe Gui, Wei Wu et al. · Clinical Cancer Research · 2019 · 104 citations · Full text

Medicine, Oncology, Pharmacology +17

Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma

Qibiao Wu, Haley Ellis, Giulia Siravegna et al. · Clinical Cancer Research · 2023 · 78 citations · Full text

Medicine, Oncology, Pharmacology +17